For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow gems #115
Wednesday 20 November 2019, 12:00 AM

“Extreme care needed with sodium valproate in pregnancy or women of childbearing potential”
Sodium valproate should not be used: in girls or women of childbearing potential, unless other treatments are ineffective or not tolerated; during pre
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
References: 1. https://bit.ly/34aHU3Y (Medsafe, 4 March 2019).
2. https://bit.ly/31R9ykH (BPACnz 2018).
3. https://bit.ly/2otZnVO (ACC 2019).